Standout Papers

CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Tre... 2005 2026 2012 2019 665
  1. CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment (2005)
    Yan Jin, Zeruesenay Desta et al. JNCI Journal of the National Cancer Institute
  2. Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update (2014)
    Kristine R. Crews, Andrea Gaedigk et al. Clinical Pharmacology & Therapeutics

Immediate Impact

2 by Nobel laureates 27 from Science/Nature 59 standout
Sub-graph 1 of 22

Citing Papers

Future therapies for cystic fibrosis
2023 Standout
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
2023 StandoutNature
1 intermediate paper

Works of Todd C. Skaar being referenced

Opportunity for pharmacogenomic testing in patients with cystic fibrosis
2021
Estrogen Receptor Genotypes, Menopausal Status, and the Lipid Effects of Tamoxifen
2007

Author Peers

Author Last Decade Papers Cites
Todd C. Skaar 3119 2376 2901 209 8.2k
Zeruesenay Desta 2494 2324 3838 165 8.4k
David A. Flockhart 3836 4207 5420 252 15.0k
Elke Schaeffeler 1529 3285 1751 178 9.4k
Chantal Guillemette 1054 2167 2902 185 8.1k
Michelle Whirl‐Carrillo 1806 1545 5302 104 9.5k
Jürgen Brockmöller 1103 3953 5030 235 13.5k
Miki Nakajima 782 2959 4685 265 10.8k
Ingolf Cascorbi 1079 5542 2644 232 12.8k
Andrea Gaedigk 1733 2904 8587 235 13.2k
Ron H. N. van Schaik 747 2653 2691 239 8.9k

All Works

Loading papers...

Rankless by CCL
2026